$ARCT News Article - Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases https://marketwirenews.com/news-releases/ultr...81370.html
(0)
(0)
Arcturus Therapeutics Ltd. (ARCT) Stock Research Links